CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuroimmunology

• Publication date

  2014-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2013.11.004PMID 24342231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

  2013influential reference
• Opsoclonus-myoclonus syndrome.

  2013cited by this paper
• A comparative study of CSF neurofilament light and heavy chain protein in MS

  2013cited by this paper
• CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids

  2013influential reference
• CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

  2013cited by this paper
• Neurofilaments as biomarkers in multiple sclerosis

  2012cited by this paper
• The C-Terminal Domains of NF-H and NF-M Subunits Maintain Axonal Neurofilament Content by Blocking Turnover of the Stationary Neurofilament Network

  2012cited by this paper
• Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis

  2012cited by this paper
• Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

  2012cited by this paper
• Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.

  2012influential reference
• Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke.

  2011cited by this paper
• Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab

  2011cited by this paper
• Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.

  2011cited by this paper
• Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

  2011cited by this paper
• Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.

  2010cited by this paper
• Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile Virus infection

  2010cited by this paper
• Neurofilament light as a prognostic marker in multiple sclerosis

  2010cited by this paper
• B cell depletion therapy for new‐onset opsoclonus‐myoclonus

  2010cited by this paper
• Dysfunctions of neuronal and glial intermediate filaments in disease.

  2009influential reference
• Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis.

  2009cited by this paper
• Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

  2009influential reference
• Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration

  2008cited by this paper
• CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis.

  2008cited by this paper
• Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

  2007cited by this paper
• New movements in neurofilament transport, turnover and disease.

  2007cited by this paper
• Multiple Sclerosis Cerebrospinal Fluid Biomarkers

  2006cited by this paper
• Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

  2005influential reference
• [The opsoclonus-myoclonus syndrome].

  2005cited by this paper
• B- and T-cell markers in opsoclonus–myoclonus syndrome

  2004cited by this paper
• Neurofilament and glial fibrillary acidic protein in multiple sclerosis

  2004influential reference
• B- and T-cell markers in opsoclonus–myoclonus syndrome: Immunophenotyping of CSF lymphocytes

  2004cited by this paper
• Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.

  2003influential reference
• Elevated neurofilament levels in neurological diseases.

  2003cited by this paper
• Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia.

  2002cited by this paper
• Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.

  2002cited by this paper
• S-100β Reflects the Extent of Injury and Outcome, Whereas Neuronal Specific Enolase Is a Better Indicator of Neuroinflammation in Patients With Severe Traumatic Brain Injury

  2001cited by this paper
• S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.

  2001cited by this paper
• Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury.

  1997cited by this paper
• Cerebrospinal Fluid of Newborn Infants Contains a Deglycosylated Form of the Intermediate Filament Nestin

  1996cited by this paper
• Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study.

  1993cited by this paper
• Opsoclonus-myoclonus syndrome: correlation of radiographic and pathological observations

  1989cited by this paper
• Neuropathologic findings in a patient with neuroblastoma and myoclonic encephalopathy.

  1979cited by this paper
• Clinics in Developmental Medicine

  1965cited by this paper

• Biomarkers on anti-N-methyl-D-aspartate receptor encephalitis

  2025cites this paper
• Síndrome opsoclonía-mioclonía asociado a enfermedad diarreica persistente: Reporte de caso en lactante menor masculino

  2023cites this paper
• Opsoclonus Myoclonus Syndrome in a Case of Severe Acute Malnutrition in Children: A Case Report

  2022cites this paper
• Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington’s disease

  2022cites this paper
• Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children

  2022cites this paper
• Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis

  2022cites this paper
• Longitudinal Evaluation of Magnetic Resonance Spectroscopy Metabolites as Biomarkers in Huntington’s Disease Running Title: MRS Metabolites in Huntington’s Disease

  2021cites this paper
• Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy

  2021cites this paper
• Serum Neurofilament Levels in Children With Febrile Seizures and in Controls

  2020cites this paper
• Targets and Antibody Formats for Immunotherapy of Neuroblastoma

  2020cites this paper
• Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis

  2020cites this paper
• Circulating Neurofilament Light Chain Is Associated With Survival After Pediatric Cardiac Arrest*

  2020cites this paper
• Moving Forward on Acquired Demyelinating Syndromes : Diagnosis, Disease Course and Outcome

  2019cites this paper
• NFL is a marker of treatment response in children with SMA treated with nusinersen

  2019cites this paper
• Eye Movement Disorders

  2019cites this paper
• Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

  2018cites this paper
• Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.

  2018cites this paper
• Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children

  2018cites this paper
• High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome

  2018cites this paper
• Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

  2018cites this paper
• Standardised guidelines and reference networks for treating neuroinflammatory conditions in children are lacking

  2018cites this paper
• Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma.

  2018cites this paper
• Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis

  2018cites this paper
• Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study.

  2018cites this paper
• Rituximab, IVIg, and Tetracosactide (ACTH1–24) Combination Immunotherapy (“RITE-CI”) for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations

  2017cites this paper
• Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges.

  2017cites this paper
• Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.

  2017cites this paper
• Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment

  2016cites this paper
• The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder

  2016cites this paper
• Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

  2016cites this paper
• Neurological Complications of Pediatric Cancer

  2016cites this paper
• Paving the path to HIV neurotherapy: Predicting SIV CNS disease.

  2015influential citation
• A study of classical and novel markers of disease in multiple sclerosis

  2015cites this paper